secwatch / observer
8-K filed July 25, 2023, 7:59 PM ET ticker TRU CIK 0001552033
earnings confidence high sentiment neutral materiality 0.65

TransUnion Q2 revenue $968M (+2%); net income $54M vs $96M YoY; FY guidance maintained

TransUnion

2023-Q2 EPS reported $0.55 revenue$1,908,200,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

TransUnion reported the quarter ended June 30, 2023 results: revenue $968 million, net income $54 million, EPS $0.28. Guidance reaffirmed.

Period
the quarter ended June 30, 2023
Revenue
$968 million
Net income
$54 million
EPS
$0.28
Guidance
reaffirmed
Result
reported results
Exact text from the filing
CHICAGO, July 25, 2023 - TransUnion (NYSE: TRU) (the “Company”) today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Results Revenue: • Total revenue for the quarter was $968 million, an increase of 2 percent (3 percent on a constant currency basis), compared with the second quarter of 2022. Earnings: • Net income attributable to TransUnion was $54 million for the quarter, compared with $96 million for the second quarter of 2022. Diluted earnings per share was $0.28, compared with $0.49 in the second quarter of 2022. Net income attributable to TransUnion margin was 5.6 percent, compared with 10.1 percent in the second quarter of 2022. • Adjusted Net Income was $166 million for the quarter, compared with $190 million for the second quarter of 2022. Adjusted Diluted Earnings per Share was $0.86, compared with $0.98 in the second quarter of 2022. • Adjusted EBITDA was $339 million for the quarter, a decrease of 3 percent (2 percent on a constant curre
View on SEC.gov

Browse all earnings releases →

TransUnion filing history →

Source: SEC EDGAR
accession 0001552033-23-000037
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.